Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of PHMMF will - over the next 2 Weeks and hit - by . In that time frame, PHMMF's share price is expected to range between - and -.
BearishAverageBullishPHMMF shares rose +7.81% in Friday, December 19, 2025's trading session, rising from a previous close of $86.26 to move at $93.00. The stock demonstrated notable intraday movement (see PHMMF's key stats for a full breakdown), fluctuating between $93.00 and $93.00, a 0 trading range. While recent weeks have seen some volatility, PHMMF has managed to secure a -6.91% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 216 shares changing hands, 822 fewer than the previous session. This amounted to $20.09K in total market activity.
Will PHMMF Continue Its Trend?
According to analyst ratings and projections for PHMMF, Pharma Mar, S.A. shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for PHMMF currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 25 negative trading days within the past 30 sessions. Based on the PHMMF stock forecast, now is not the best time to buy PHMMF stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on PHMMF covering social and institutional perspectives.
PHMMF Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into PHMMF's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 68.97% to 93.66%) indicate the stock is leaning toward a strong bullish momentum phase. The 50-day RSI, at 52.50%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 53.20%, maintains a neutral outlook for the long term. Insights into PHMMF's shareholder base show how institutional investors are positioning themselves during these momentum shifts

